MetabolomicsWorkbenchapplication/xmlhttp://www.metabolomicsworkbench.org/rest/study/study_id/ST001069/mwtabprimary200OKMetabolomicsMass SpectrometryESITuberculosisHomo Sapienshttp://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST001069Sample Type:INDEXSample Type:HealthySample Type:RecurSample Type:TST+Sample Type:FailSample Type:TST-Sample Type:CureColorado State UniversityUrineReversed phase POSITIVE ION MODE/TOF. Reversed phase POSITIVE ION MODE/QTOF.MetabolomicsWorkbenchSLC1G(RS)-Leucine, urinary levels, urinary aspects., peptides, Leucine, L, L Isomer, Leuzin, patient, L-Isomer, (+-)-Leucine, Client, Peptide, L-Leucine, polypeptide, peptide, Polypeptides, L-Isomer Leucine, peptido, Patient, Clients, DL-Leucine, 2-amino-4-methylpentanoic acid, core, Peptid, peptidos, Polypeptide, Hleu, Leucin, LeuFEZL, VSD1, ZFP312, backward, reversed., TOF, FEZ, TACHD, ZNF312, reversed, ASD2falseEvaluation of Seryl-leucine core 1 O-glycosylated peptide (SLC1G) in TB patient urineST0010699606